499 related articles for article (PubMed ID: 27167455)
1. Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.
Koth VS; Figueiredo MA; Salum FG; Cherubini K
Dentomaxillofac Radiol; 2016; 45(7):20160049. PubMed ID: 27167455
[TBL] [Abstract][Full Text] [Related]
2. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.
Hutchinson M; O'Ryan F; Chavez V; Lathon PV; Sanchez G; Hatcher DC; Indresano AT; Lo JC
J Oral Maxillofac Surg; 2010 Sep; 68(9):2232-40. PubMed ID: 20728032
[TBL] [Abstract][Full Text] [Related]
3. A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography.
Hamada H; Matsuo A; Koizumi T; Satomi T; Chikazu D
J Craniomaxillofac Surg; 2014 Sep; 42(6):924-9. PubMed ID: 24503386
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaw: what we have learned.
Tabari E; Sikavi C
Alpha Omegan; 2014; 107(2):8-15. PubMed ID: 25269218
[TBL] [Abstract][Full Text] [Related]
5. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
[TBL] [Abstract][Full Text] [Related]
7. [Risk assessment of bisphosphonate-related osteonecrosis of the jaw based on CBCT scans].
Koppány F; Joób-Fancsaly Á; Németh Z; Belik AA; Vaszilkó M; Varmuzsa EM; Csomó KB
Orv Hetil; 2020 May; 161(21):867-872. PubMed ID: 32427571
[TBL] [Abstract][Full Text] [Related]
8. A case of early detection of bisphosphonate-related osteonecrosis of the jaw.
Mori M; Koide T; Matsui Y; Matsuda T
Indian J Pharmacol; 2015; 47(3):334-5. PubMed ID: 26069377
[TBL] [Abstract][Full Text] [Related]
9. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
Yoneda T
Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-related osteonecrosis of the jaws.
Kushner GM; Alpert B
Curr Opin Otolaryngol Head Neck Surg; 2011 Aug; 19(4):302-6. PubMed ID: 21677585
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
12. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases.
Bagan JV; Hens-Aumente E; Leopoldo-Rodado M; Poveda-Roda R; Bagan L
Oral Oncol; 2012 Aug; 48(8):753-7. PubMed ID: 22401869
[TBL] [Abstract][Full Text] [Related]
14. Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.
Koth VS; Figueiredo MA; Salum FG; Cherubini K
Dentomaxillofac Radiol; 2017 Apr; 46(4):20160260. PubMed ID: 28107028
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-related osteonecrosis of the jaws--a case report.
Kamoh AK; Ogle O
Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
[TBL] [Abstract][Full Text] [Related]
16. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
17. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
18. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
[TBL] [Abstract][Full Text] [Related]
19. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
Aoki K; Matsunaga S; Ito S; Shibahara T; Nomura T; Matsuzaki H; Abe S; Yamaguchi A
J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
[TBL] [Abstract][Full Text] [Related]
20. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
